SCHEMBL6976973

SCHEMBL6976973

CC1CCN(C(=O)c2ccc3c(c2)CCCN3)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.57
MAPT P10636 1/20 0.57
HPGD P15428 4/20 0.54
ALDH1A1 P00352 2/20 0.54
TP53 P04637 1/20 0.54
NPC1 O15118 1/20 0.52
RAB9A P51151 1/20 0.52
TSHR P16473 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
ACHE P22303 3/20 0.49
MASP2 O00187 1/20 0.48
F2 P00734 1/20 0.48
KMT2A Q03164 1/20 0.46
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46
CA14 Q9ULX7 1/20 0.46
CRBN Q96SW2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30031951 0.89 MAPT (0.58) KDM4EMAPTHPGDALDH1A1ACHE
SCHEMBL6982244 0.85 KDM4E (0.64) KDM4EMAPTHPGDALDH1A1NPC1
SCHEMBL6980782 0.85 KDM4E (0.60) KDM4EMAPTHPGDALDH1A1ACHE
SCHEMBL6978588 0.82 KDM4E (0.59) KDM4EMAPTHPGDALDH1A1MASP2
SCHEMBL15880405 0.81 CRBN (0.54) KDM4EMAPTALDH1A1ACHECRBN
SCHEMBL11042646 0.80 CRBN (0.60) HPGDALDH1A1TP53NPC1RAB9A
SCHEMBL30226880 0.80 CRBN (0.58) KDM4EMAPTHPGDALDH1A1TSHR
SCHEMBL22226793 0.79 PDK1 (0.47) HPGDALDH1A1TP53NPC1RAB9A
SCHEMBL22226394 0.79 CRBN (0.57) KDM4EMAPTHPGDALDH1A1NPC1
SCHEMBL30226900 0.79 CRBN (0.57) KDM4EMAPTHPGDALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed